NEUROPACE, INC. Stock-Based Compensation
NEUROPACE, INC. (NPCE) reported Stock-Based Compensation of $4.58 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-11.
Financial Statements › Cash Flow › Operating Activities
us-gaap:ShareBasedCompensation · last filed 2026-08-11
- NEUROPACE, INC. share-based payment arrangement, noncash expense for the quarter ending 2026-06-30 was $2.30M, a 28.66% decline year-over-year.
- NEUROPACE, INC. share-based payment arrangement, noncash expense for the quarter ending 2026-03-31 was $2.28M, a 13.25% decline year-over-year.
- NEUROPACE, INC. share-based payment arrangement, noncash expense for the quarter ending 2025-12-31 was $2.61M, a 0.15% increase year-over-year.
- NEUROPACE, INC. share-based payment arrangement, noncash expense for the quarter ending 2025-09-30 was $2.63M, a 1.43% increase year-over-year.
- NEUROPACE, INC. share-based payment arrangement, noncash expense for fiscal 2025 was $11.09M, a 7.85% increase from fiscal 2024.
- NEUROPACE, INC. share-based payment arrangement, noncash expense for fiscal 2024 was $10.28M, a 7.57% increase from fiscal 2023.
- NEUROPACE, INC. share-based payment arrangement, noncash expense for fiscal 2023 was $9.56M, a 14.48% increase from fiscal 2022.
- NEUROPACE, INC. share-based payment arrangement, noncash expense for fiscal 2022 was $8.35M, a 94.71% increase from fiscal 2021.
| Period end | Share-based Payment Arrangement, Noncash Expense 3 month | Share-based Payment Arrangement, Noncash Expense 6 month | Share-based Payment Arrangement, Noncash Expense 9 month | Share-based Payment Arrangement, Noncash Expense 12 month |
|---|---|---|---|---|
| 2026-06-30 | $2.30M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-11 | $4.58M 10-Q · filed 2026-08-11 | $7.19M derived: sum of 3 quarters · filed 2026-08-11 | $9.82M derived: sum of 4 quarters · filed 2026-08-11 |
| 2026-03-31 | $2.28M 10-Q · filed 2026-05-12 | $4.88M derived: sum of 2 quarters · filed 2026-05-12 | $7.51M derived: sum of 3 quarters · filed 2026-05-12 | $10.74M derived: sum of 4 quarters · filed 2026-08-11 |
| 2025-12-31 | $2.61M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-03 | $5.24M derived: sum of 2 quarters · filed 2026-03-03 | $8.46M derived: sum of 3 quarters · filed 2026-08-11 | $11.09M 10-K · filed 2026-03-03 |
| 2025-09-30 | $2.63M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-04 | $5.86M derived: sum of 2 quarters · filed 2026-08-11 | $8.48M 10-Q · filed 2025-11-04 | $11.09M derived: sum of 4 quarters · filed 2026-08-11 |
| 2025-06-30 | $3.23M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-11 | $5.85M 10-Q · filed 2026-08-11 | $8.46M derived: sum of 3 quarters · filed 2026-08-11 | $11.05M derived: sum of 4 quarters · filed 2026-08-11 |
| 2025-03-31 | $2.63M 10-Q · filed 2026-05-12 | $5.23M derived: sum of 2 quarters · filed 2026-05-12 | $7.82M derived: sum of 3 quarters · filed 2026-05-12 | $10.37M derived: sum of 4 quarters · filed 2026-05-12 |
| 2024-12-31 | $2.60M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-03 | $5.19M derived: sum of 2 quarters · filed 2026-03-03 | $7.74M derived: sum of 3 quarters · filed 2026-03-03 | $10.28M 10-K · filed 2026-03-03 |
| 2024-09-30 | $2.59M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-04 | $5.14M derived: sum of 2 quarters · filed 2025-11-04 | $7.68M 10-Q · filed 2025-11-04 | $10.04M derived: sum of 4 quarters · filed 2025-11-04 |
| 2024-06-30 | $2.55M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-12 | $5.09M 10-Q · filed 2025-08-12 | $7.45M derived: sum of 3 quarters · filed 2025-08-12 | $9.87M derived: sum of 4 quarters · filed 2025-08-12 |
| 2024-03-31 | $2.54M 10-Q · filed 2025-05-13 | $4.90M derived: sum of 2 quarters · filed 2025-05-13 | $7.32M derived: sum of 3 quarters · filed 2025-05-13 | $9.97M derived: sum of 4 quarters · filed 2025-05-13 |
| 2023-12-31 | $2.36M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-04 | $4.78M derived: sum of 2 quarters · filed 2025-03-04 | $7.43M derived: sum of 3 quarters · filed 2025-03-04 | $9.56M 10-K · filed 2025-03-04 |
| 2023-09-30 | $2.42M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-12 | $5.08M derived: sum of 2 quarters · filed 2024-11-12 | $7.20M 10-Q · filed 2024-11-12 | $9.28M derived: sum of 4 quarters · filed 2024-11-12 |
| 2023-06-30 | $2.65M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-13 | $4.78M 10-Q · filed 2024-08-13 | $6.86M derived: sum of 3 quarters · filed 2024-08-13 | $9.04M derived: sum of 4 quarters · filed 2024-08-13 |
| 2023-03-31 | $2.13M 10-Q · filed 2024-05-08 | $4.20M derived: sum of 2 quarters · filed 2024-05-08 | $6.38M derived: sum of 3 quarters · filed 2024-05-08 | $8.99M derived: sum of 4 quarters · filed 2024-05-08 |
| 2022-12-31 | $2.08M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-05 | $4.26M derived: sum of 2 quarters · filed 2024-03-05 | $6.86M derived: sum of 3 quarters · filed 2024-03-05 | $8.35M 10-K · filed 2024-03-05 |
| 2022-09-30 | $2.18M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-06 | $4.79M derived: sum of 2 quarters · filed 2023-11-06 | $6.27M 10-Q · filed 2023-11-06 | $8.15M derived: sum of 4 quarters · filed 2023-11-06 |
| 2022-06-30 | $2.60M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-08 | $4.09M 10-Q · filed 2023-08-08 | $5.97M derived: sum of 3 quarters · filed 2023-08-08 | $7.07M derived: sum of 4 quarters · filed 2023-08-08 |
| 2022-03-31 | $1.49M 10-Q · filed 2023-05-04 | $3.36M derived: sum of 2 quarters · filed 2023-05-04 | $4.47M derived: sum of 3 quarters · filed 2023-05-04 | $5.57M derived: sum of 4 quarters · filed 2023-05-04 |
| 2021-12-31 | $1.88M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-02 | $2.98M derived: sum of 2 quarters · filed 2023-03-02 | $4.09M derived: sum of 3 quarters · filed 2023-03-02 | $4.29M 10-K · filed 2023-03-02 |
| 2021-09-30 | $1.11M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-08 | $2.21M derived: sum of 2 quarters · filed 2022-11-08 | $2.41M 10-Q · filed 2022-11-08 | $2.90M derived: sum of 4 quarters · filed 2022-11-08 |
| 2021-06-30 | $1.10M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-11 | $1.30M 10-Q · filed 2022-08-11 | $1.79M derived: sum of 3 quarters · filed 2022-08-11 | $2.09M derived: sum of 4 quarters · filed 2022-08-11 |
| 2021-03-31 | $202.00K 10-Q · filed 2022-05-12 | $689.00K derived: sum of 2 quarters · filed 2022-05-12 | $990.00K derived: sum of 3 quarters · filed 2022-05-12 | $1.28M derived: sum of 4 quarters · filed 2022-05-12 |
| 2020-12-31 | $487.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-10 | $788.00K derived: sum of 2 quarters · filed 2022-03-10 | $1.08M derived: sum of 3 quarters · filed 2022-03-10 | $1.38M 10-K · filed 2022-03-10 |
| 2020-09-30 | $301.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-10 | $591.00K derived: sum of 2 quarters · filed 2021-11-10 | $892.00K 10-Q · filed 2021-11-10 | |
| 2020-06-30 | $290.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-12 | $591.00K 10-Q · filed 2021-08-12 | ||
| 2020-03-31 | $301.00K 10-Q · filed 2021-06-03 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Sight Sciences, Inc. (SGHT) | United States | $0.478B | -9.95 |
| ClearPoint Neuro, Inc. (CLPT) | United States | $0.446B | -15.74 |
| TACTILE SYSTEMS TECHNOLOGY INC (TCMD) | United States | $0.519B | 27.16 |
| CERUS CORP (CERS) | United States | $0.525B | -86.40 |
| CARLSMED, INC. (CARL) | United States | $0.405B | |
| DELCATH SYSTEMS, INC. (DCTH) | United States | $0.558B | 820.33 |
| Orthofix Medical Inc. (OFIX) | $0.373B | ||
| SS Innovations International, Inc. (SSII) | $0.589B | -64.06 | |
| ORTHOPEDIATRICS CORP (KIDS) | United States | $0.592B | |
| Orchestra BioMed Holdings, Inc. (OBIO) | United States | $0.356B | -4.39 |